The S&P opened in negative territory as the week began with the Justice Department indictment of former Trump campaign chairman Paul Manafort. The weakness in...
Shares of Care.com (CRCM), the operator of an online marketplace for finding and managing family care, are sliding after short seller "Batman Research" published a...
Shares of Bristol-Myers Squibb (BMY) are on the rise after competitor Merck (MRK) announced it is withdrawing its European application for a combination regimen featuring...
Goldman Sachs analyst David Tamberrino downgraded General Motors (GM) to Sell from Neutral saying his price target of $32 offers 28% potential downside. The analyst...
Barclays analyst Geoff Meacham downgraded Merck (MRK) to Equal Weight and cut his price target for the shares to $62 from $72. The healthcare company...
Celgene (CELG) has announced that its Ozanimod, a novel, oral, selective sphingosine 1-phosphate 1 and 5 receptor modulator, demonstrated superiority versus Biogen's (BIIB) Avonex in...